Supreme Court restricting mifepristone would be a "slippery slope" for future drugs

Contributing sentiments towards policy:

55% : During the hearing, much of the discussion centered around questioning whether the group of anti-abortion doctors and organizations had a right to challenge the FDA's approval of mifepristone in the first place and that there appears to be a mismatch between the claimed injury of the plaintiffs and what they are seeking in return.
50% : In April 2023, a Trump-appointed judge named Matthew J. Kacsmaryk of the U.S. District Court for the Northern District of Texas ruled in agreement with the plaintiffs, an organization of anti-abortion activists backed by the Christian right-wing lobbying group Alliance Defending Freedom, kicking off nearly two years of litigation around access to the medication -- leading to yesterday's oral arguments.
36% : Abortion is totally banned or partially banned in 21 states.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.